glp 1 drugs in development GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits Evolution of GLP‐1 Receptor Agonists

Beta-Sitosterol exerts its anticancer effects in cancer cells by activating caspase-3 , caspase-8 , and caspase-9 , mediating PARP inactivation, MMP loss, altered Bcl-2-Bax ratio, and cytochrome c release

We applied bleaching correction between frames to compensate for switching fatigue

Stanley et al., 2011)

In the future, manufacturers need to continuously monitor regulatory developments and market demands to promote their research and development as well as industrialization processes

The average duration for returning to play was 21.1 3.1 days for the PRP group and 25 2.8 days for the control group (P = 0.001)